Sanofi (SNY) Net Cash Flow (2009 - 2026)

Sanofi has disclosed Net Cash Flow across 9 years of filings, most recently posting $918.3 million for Q2 2026.

• In Q2 2026, Net Cash Flow fell 88.52% year-over-year to $918.3 million; the TTM figure through Jun 2026 stood at -$9.2 billion (down 245.54% YoY), while the FY2025 annual figure was -$11.9 billion, down 1039.71% from the prior year.
• Net Cash Flow came in at $918.3 million for Q2 2026 at Sanofi, up from -$2.5 billion in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $8.1 billion in Q3 2024 to a low of -$13.6 billion in Q4 2023.
• Average Net Cash Flow over 5 years is -$232.9 million, with a median of $918.3 million recorded in 2026.
• Year-over-year, Net Cash Flow tumbled 1539.3% in 2023 and surged 412.42% in 2025.
• Over 5 years, Net Cash Flow stood at $944.7 million in 2022, then plunged by 1539.3% to -$13.6 billion in 2023, then climbed by 22.4% to -$10.6 billion in 2024, then increased by 13.0% to -$9.2 billion in 2025, then jumped by 110.0% to $918.3 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $918.3 million in Q2 2026, -$2.5 billion in Q1 2026, and -$9.2 billion in Q4 2025.